Vazirani Asset Management LLC bought a new stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 37,749 shares of the biopharmaceutical company’s stock, valued at approximately $4,296,000. Horizon Therapeutics Public comprises 7.3% of Vazirani Asset […]